Investor Relations

Our Investor Relations and Communications Mission

To always communicate with transparency and credibility.

Why Invest in Impax?

We are rapidly transforming into a specialty pharmaceutical company and believe it will be a significant driver of our future success in both generics and branded pharmaceuticals.

Why Invest in Impax?

We continue to expand our pipeline of product offerings which are aimed to drive growth into the future.

Latest Event

Latest Events

March 01, 2017 Impax Laboratories Fourth Quarter and FY 2016 Earnings Conference Call

To access the call through a conference line, dial (877) 356-3814 (in the U.S.) and (706) 758-0033 (international callers). The conference ID is 58242935.

A replay of the conference call will be available for seven days shortly after the call. To access the replay, dial (855) 859-2056 (in the U.S.) and (404) 537-3406 (international callers). The access code for the replay is 58242935.

Webcast

Documents

Date Download
April 21, 2016 2016 Proxy Statement 614 KB
April 21, 2016 2015 Annual Report 2.18 MB
Name*  
E-mail*  
Comments
Enter Text:
 
Enter the code shown above.